pGS-scAAV-ITR141-Kan-CAG

Description

A GenScript-innovative self-complementary AAV scAAV transfer vector engineered with superior ITR stability and high plasmid yield. This vector includes a truncated AAV2 ITR sequence, a kanamycin resistance gene, the CAG promoter for strong and ubiquitous transgene expression, and an SV40 polyadenylation signal. Ideal for versatile gene therapy applications in therapeutic development pipelines.